Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Allergan

Status and phase: Completed; Phase 3

Conditions: Ocular Hypertension

Treatments: Drug: brimonidine/timolol fixed combination

Study type: Interventional

Funder types: Industry

Identifiers

NCT00332384

190342-012T

Details and patient eligibility

About

The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

Enrollment: 573 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
• Patient requires IOP-lowering drug in both eyes

Exclusion criteria

• Uncontrolled medical conditions
• contraindication to beta-adrenoceptor antagonist or brimonidine therapy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind